RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000084.xml
Synthesis 2011(17): 2848-2858
DOI: 10.1055/s-0030-1260165
DOI: 10.1055/s-0030-1260165
PAPER
© Georg Thieme Verlag
Stuttgart ˙ New York
Synthesis and Structure of Fluorescent Chelate Boron Complexes of 4-Anilinomethylidene-1-benzazepine-2,5-dione Ligands
Weitere Informationen
Received
7 April 2011
Publikationsdatum:
08. August 2011 (online)
Publikationsverlauf
Publikationsdatum:
08. August 2011 (online)

Abstract
As analogues to the paullone kinase inhibitor family, boron chelate complexes of 4-anilinomethylidene-1-benzazepine-2,5-diones were prepared by reacting the ligands with boron trifluoride etherate or triphenylborane. The structures of the novel heterocyclic ring systems were established by X-ray structure analysis of two representative derivatives. The stability of the compounds in dimethylsulfoxide solution is dependent on the electronic properties of the aryl ring substituents. The fluorescent properties of the molecules are suitable for imaging the intracellular compound distribution by confocal laser microscopy.
Key words
boron - chelates - lactams - ligands - spectroscopy
- Supporting Information for this article is available online:
- Supporting Information
- 1
Zhang J.Yang PL.Gray NS. Nat. Rev. Cancer 2009, 9: 28 - 2
Hunter T. J. Clin. Invest. 2007, 117: 2036 - 3
Ghose AK.Herbertz T.Pippin DA.Salvino JM.Mallamo JP. J. Med. Chem. 2008, 51: 5149 - 4
Kunick C.Zeng Z.Gussio R.Zaharevitz D.Leost M.Totzke F.Schächtele C.Kubbutat MHG.Meijer L.Lemcke T. ChemBioChem 2005, 6: 541 - 5
Pies T.Schaper K.-J.Leost M.Zaharevitz DW.Gussio R.Meijer L.Kunick C. Arch. Pharm. Pharm. Med. Chem. 2004, 337: 486 - 6
Wieking K.Knockaert M.Leost M.Zaharevitz DW.Meijer L.Kunick C. Arch. Pharm. Pharm. Med. Chem. 2002, 335: 311 - 7
Egert-Schmidt A.-M.Dreher J.Dunkel U.Kohfeld S.Preu L.Weber H.Ehlert JE.Mutschler B.Totzke F.Schächtele C.Kubbutat MHG.Baumann K.Kunick C. J. Med. Chem. 2010, 53: 2433 - 8
Barnes KR.Blois J.Smith A.Yuan H.Reynolds F.Weissleder R.Cantley LC.Josephson L. Bioconjugate Chem. 2008, 19: 130 - 9
Marks DL.Bittman R.Pagano RE. Histochem. Cell Biol. 2008, 130: 819 - 10
Xia M.Wu B.Xiang G. J. Fluorine Chem. 2008, 129: 402 - 11
Macedo FP.Gwengo C.Lindeman SV.Smith MD.Gardinier JR. Eur. J. Inorg. Chem. 2008, 3200 - 12
Chen W.-Y.Gilman NW. J. Heterocycl. Chem. 1983, 20: 663 - 13
Dutta MC.Chanda K.Karim E.Vishwakarma JN. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 2004, 43: 2471 - 14
Al-Saleh B.El-Apasery MA.Abdel-Aziz RS.Elnagdi MH. J. Heterocycl. Chem. 2005, 42: 563 - 15
Zhou Y.Xiao Y.Chi S.Qian X. Org. Lett. 2008, 10: 633 - 16
Ulrich G.Goze C.Goeb S.Retailleau P.Ziessel R. New J. Chem. 2006, 30: 982 - 17
Liu Q.-D.Mudadu MS.Thummel R.Tao Y.Wang S. Adv. Funct. Mater. 2005, 15: 143 - 18
Kunick C. Arch. Pharm. (Weinheim, Ger.) 1991, 324: 579 - 19
Reichwald C.Shimony O.Dunkel U.Sacerdoti-Sierra N.Jaffe CL.Kunick C. J. Med. Chem. 2008, 51: 659 - 20
Xie X.Lemcke T.Gussio R.Zaharevitz DW.Leost M.Meijer L.Kunick C. Eur. J. Med. Chem. 2005, 40: 655 - 21
Schäfer S.Ott I.Gust R.Sheldrick WS. Eur. J. Inorg. Chem. 2007, 3034